Neostigmine

Neostigmine

SCHEMBL8026154

CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHE

The experimentally established mechanism targets of Neostigmine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 13/20 1.00
BCHE P06276 7/20 1.00
LMNA P02545 4/20 1.00
MEN1 O00255 1/20 0.97
KMT2A Q03164 1/20 0.97
NPSR1 Q6W5P4 1/20 0.97
RAB9A P51151 1/20 0.53
GLA P06280 2/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
NCEH1 Q6PIU2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Neostigmine SCHEMBL29603805 1.00 ACHE (1.00) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL34419 1.00 ACHE (1.00) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL29618009 0.98 ACHE (1.00) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL30029632 0.98 ACHE (0.97) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL20425365 0.98 ACHE (0.97) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL41128 0.98 ACHE (1.00) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL16228482 0.98 ACHE (0.97) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL7576189 0.97 ACHE (0.94) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL7633009 0.94 ACHE (0.88) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL2028206 0.93 ACHE (0.89) ACHEBCHELMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675838-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS Puretecch LYT, Inc. (US) 2020-07-08 EP disclosed
WO-2019046491-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS ARIYA THERAPEUTICS, INC. (US) 2019-03-07 WO disclosed
EP-0941224-A4 MULTIVALENT SALTS OF PYRIDOSTIGMINE AND RELATED COMPOUNDS ICN PHARMACEUTICALS (US) 2000-01-12 EP disclosed
EP-0941224-A1 MULTIVALENT SALTS OF PYRIDOSTIGMINE AND RELATED COMPOUNDS ICN Pharmaceuticals, Inc. (US) 1999-09-15 EP disclosed
WO-1998022458-A1 MULTIVALENT SALTS OF PYRIDOSTIGMINE AND RELATED COMPOUNDS ICN PHARMACEUTICALS, INC. (US) 1998-05-28 WO disclosed